*click on image to view study
Patented oral therapy for improving vision in retinal and optic nerve diseases
Protects and improves function of retinal photoreceptors and optic nerve fibres
Ultra concentrated fish oils with more than 95% EPA and DHA
Virtually no environmental toxins
Eyetas puplished pre-clinical and clinical evidence
Conditions
Dry Age-Related Macular Degeneration and Stargardt Disease (Clinical Study)
Age-related macular degeneration (AMD) is the leading cause of vision loss in people age 50 or older. Treatment for AMD is currently limited and often ineffective. Eyetas can support your vision by…
Read More
Macular Degeneration
(Preclinical Study)
Macular degeneration is a group of conditions that typically affect older adults, leading to the gradual loss of central vision. While there is currently no cure, there is still hope for slowing the progression of the disease. Eyetas is specially formulated to counteract photoreceptor damage by repairing and regenerating retinal cells.
Read More
Stargardt's disease
(Preclinical Study)
Stargardt disease is an inherited eye condition that leads to gradual central vision loss, often beginning in childhood or adolescence. While there's no cure, treatments can slow its progression. Eyetas is formulated to protect and repair retinal cells, offering hope for preserving vision in those affected by Stargardt disease.
Read More
Rat Model of Anterior Ischemic Optic Neuropathy ( rAION) ( PreClinical Study)
Non-arteritic anterior ischaemic optic neuropathy (NAAION) is a condition where the vessels supplying blood to the optic nerve become blocked leading to loss of oxygen supply to the optic nerve and finally its damage. Damage to the optic nerve can lead to irreversible vision loss due to damage on the neural tissue. Retinal cell survival is now possible when supplemented with Eyetas dietary supplements. EYETAS has proved to improve vision and protect retinal cells, through its neuroprotective effects. Anti-inflammatory response with Omega 3 supplementation is evident at a cellular level.
Read More
Why Eyetas
Eyetas is inspired by our long-term research and clinical practice in ophthalmology, to provide highest quality nutritional care for your eyes. It contains high concentrations of ‘essential’ Omega-3 fatty acids, namely the eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Our body is not able to produce them and therefore they must be supplied through diet. In retinal and optic nerve diseases the demand of essential Omega-3 fatty acids is high and oral supplementation is recommended to enhance tissue repair and promote regeneration.
Message from Dr Tassos Georgiou
(Clinical Professor in Ophthalmology)
Eyetas has transformed the way I treat retinal diseases. Its clinically proven results not only improve vision but also restoring hope for my patients.
“Eyetas is a true breakthrough in eye care.”
English 
Russian